Nov. 03, 2025 (GLOBE NEWSWIRE) -- Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced three presentations ... and ...

AAVivo, Inc., a pioneering biotechnology company developing novel, precision targeted biotherapeutics to enable in vivo generation of CAR-T cells, today announced a presentation at the Society for ...

Beijing Tsingke Biotech Co., Ltd., a pioneer in molecular manufacturing, showcased its next-generation integrated platforms at the 2025 Festival of Biologics in Basel. Over 2,000 biotech experts from ...

Q3 2025 Earnings Call Transcript October 29, 2025 BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Research and Development Expenses -- $9.6 million in the third quarter of 2025, down from $12.3 million in Q3 2024, due to ...

The global cancer-therapy landscape is undergoing a rapid evolution toward precision drug-delivery systems designed to boost efficacy, ...

Nanomedicine Innovations Transforming Oncology Drug Delivery And Bioavailability - Financial News Media. NetworkNewsWire Editorial Coverage New York, NY – October 29, 2025 – The global cancer-therapy ...

NetworkNewsWire Editorial Coverage NEW YORK, Oct. 29, 2025 /PRNewswire/ -- The global cancer-therapy landscape is undergoing a rapid evolution toward ...

CAZENOVIA — On Tuesday, Nov. 11, at 6:15 p.m., the Cazenovia Garden Club will welcome citizen scientist Jim English to the Cazenovia Public Library Community Room to present on the history of the ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...